2026-04-29T04:08:33Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/236312024-11-29T00:48:47Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967

00925njm 22002777a 4500 dc Zamanillo Campos, Rocío author Fiol-deRoque, Maria Antonia author Serrano-Ripoll, Maria Jesus author Mira-Martínez, Sofía author Llobera Cànaves, Joan author Taltavull Aparicio, Joana Maria author Leiva, Alfonso author Ripoll Amengual, Joana author Angullo Martinez, Escarlata author Socias Buades, Isabel Maria author Masmiquel, Lluis author Konieczna, Jadwiga author Zaforteza Dezcallar, María author Boronat-Moreiro, Maria Asunción author Gervilla Garcia, Elena author Ricci-Cabello, Ignacio author 2023-11-22 Aim: To evaluate the effectiveness of DiabeText, a low-intensity, multifaceted, mobile health (mHealth) intervention to support medication taking and lifestyle change targeted to people with type 2 diabetes (T2D). Design: Phase III, 12-months, two-arm (1:1 allocation ratio), randomized parallel-group trial. Methods: We will recruit 740 adults with glycated hemoglobin (A1c) >8% (>64 mmol/mol) and with at least one prescription of a non-insulin antidiabetic drug. They will be allocated to a control (usual care) group or an intervention (DiabeText messaging intervention) group. The primary outcome measure will be A1c at 12 months follow-up. Secondary outcomes will include medication possession ratio and behavioral and psychological outcomes. Discussion: Recent trials suggest that digital health interventions can effectively support diabetes self-management improving T2D control and reducing important T2D complications. In Spain this type of interventions is understudied. Impact: This trial will strengthen the evidence base of the impact of mHealth interventions to support diabetes self-management. If effective, DiabeText may offer a low-cost and highly scalable strategy to improve health at the population level in a sustainable way. Trial registration: ClinicalTrials.gov identifier NCT05006872; Official Title: Supporting People with Type 2 Diabetes in Effective Use of their Medicine Through a System Comprising Mobile Health Technology Integrated with Clinical Care. Zamanillo-Campos R, Fiol-DeRoque MA, Serrano-Ripoll MJ, Mira-Martínez S, Llobera-Canaves J, Taltavull-Aparicio JM, et al. DiabeText, a mobile health intervention to support medication taking and healthy lifestyle in adults with type 2 diabetes: Study protocol for a randomized controlled trial. Contemp Clin Trials. 2024 Jan;136:107399. https://hdl.handle.net/20.500.13003/20115 https://hdl.handle.net/20.500.12105/23631 37995967 10.1016/j.cct.2023.107399 1559-2030 Contemporary clinical trials 2-s2.0-85181718678 1127807300001 L2028676152 DiabeText, a mobile health intervention to support medication taking and healthy lifestyle in adults with type 2 diabetes: Study protocol for a randomized controlled trial